Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy

Nature Immunology(2021)10.1038/s41590-021-00958-6Source: DataRank Database

Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy is a research paper published in Nature Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 112 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access112 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 6.50)OA: greenTopics (57)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

James Clarke ORCID,Ciro Ramírez-Suástegui ORCID,Bharat Panwar ORCID,Ariel Madrigal ORCID,Serena Chee ORCID

Live enrichment

PubMed:34168370 PMC:PMC8434898 OpenAlex:https://openalex.org/W3176344645

NIH HHS

Grant: S10 OD025052

NCRR NIH HHS

Grant: S10 RR027366

Cancer Research UK

Grant: 21998

NIH HHS

Grant: S10 OD016262

National Institutes of Health

Grant: 1S10OD025052-01

NovaSeq5000 High Throughput Sequencer

National Institutes of Health

Grant: 1S10RR027366-01A1

FACSAria II Cell Sorter

National Institutes of Health

Grant: 1S10OD016262-01

Illumina HiSeq 2500 Sequencing System

FWCI

6.50

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8434898

publisherhttp://www.nature.com/articles/s41590-021-00958-6.pdf

publisherhttp://www.nature.com/articles/s41590-021-00958-6

journalhttps://doi.org/10.1038/s41590-021-00958-6

Fields of Study

Cancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCAR-T cell therapy research0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Immune Checkpoint InhibitorsT Follicular Helper CellsAnimalsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDisease Models, AnimalFemaleHumansMelanomaMice, Inbred C57BLLymphocytes, Tumor-InfiltratingCD8-Positive T-LymphocytesCell Line, TumorT-Lymphocytes, RegulatoryMiceTumor MicroenvironmentCTLA-4 AntigenProgrammed Cell Death 1 Receptor

Keywords

CTLA-4Immune checkpointCancer researchPD-L1BlockadeTumor microenvironmentImmunotherapyMelanomaImmunologyImmune systemMedicineBiologyT cellInternal medicineReceptorT Follicular Helper CellsProgrammed Cell Death 1 Receptor610Antineoplastic AgentsCD8-Positive T-LymphocytesT-Lymphocytes, RegulatoryMice, Inbred C57BLDisease Models, AnimalMiceLymphocytes, Tumor-InfiltratingCell Line, Tumor616Antineoplastic Combined Chemotherapy ProtocolsAnimalsHumansCTLA-4 AntigenFemaleImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being